<code id='C7716EF23E'></code><style id='C7716EF23E'></style>
    • <acronym id='C7716EF23E'></acronym>
      <center id='C7716EF23E'><center id='C7716EF23E'><tfoot id='C7716EF23E'></tfoot></center><abbr id='C7716EF23E'><dir id='C7716EF23E'><tfoot id='C7716EF23E'></tfoot><noframes id='C7716EF23E'>

    • <optgroup id='C7716EF23E'><strike id='C7716EF23E'><sup id='C7716EF23E'></sup></strike><code id='C7716EF23E'></code></optgroup>
        1. <b id='C7716EF23E'><label id='C7716EF23E'><select id='C7716EF23E'><dt id='C7716EF23E'><span id='C7716EF23E'></span></dt></select></label></b><u id='C7716EF23E'></u>
          <i id='C7716EF23E'><strike id='C7716EF23E'><tt id='C7716EF23E'><pre id='C7716EF23E'></pre></tt></strike></i>

          explore

          explore

          author:Wikipedia    Page View:22
          insulin biosimilar
          Last week, the FDA released a trio of guidelines clarifying the way they plan to evaluate devices that go through the 510(k) pathway. Jacquelyn Martin/AP

          Five years after promising to fix a flawed regulatory pathway widely used by medical device manufacturers, the Food and Drug Administration has issued new guidelines to improve its so-called 510(k) program that has long been lambasted for letting risky devices fall through the cracks.

          Most medical device companies do not have to test their products on people in order to secure clearance from the FDA — they simply have to show they’re “substantially equivalent” to devices already on the market, called “predicates.” This process is the 510(k) pathway, and accounts for the vast majority of new medical devices launched on the market each year. Devices cleared through this pathway include X-ray machines, muscle stimulators, and wheelchairs.

          advertisement

          Last week, the FDA released a trio of guidelines clarifying the way it plans to evaluate devices that go through the 510(k) pathway. The agency is asking manufacturers to avoid predicate devices that were recalled due to a “design-related” issue or have “unmitigated” safety concerns. Manufacturers should submit flow charts explaining why they chose their predicate device. If they have to choose one with a recall history or safety issues, they should explain how the new device addresses those problems. The FDA may also ask the manufacturer for clinical data in this case.

          Get unlimited access to award-winning journalism and exclusive events.

          Subscribe Log In

          comprehensive

          State Dept. review finds Biden bears some blame for Afghanistan failures
          State Dept. review finds Biden bears some blame for Afghanistan failures

          3:53HundredsofpeoplegathernearaU.S.AirForceC-17transportplaneattheperimeteroftheinternationalairport

          read more
          Free speech concerns arise in wake of journal editor Eisen's firing
          Free speech concerns arise in wake of journal editor Eisen's firing

          MichaelEisen,whowasfiredaseditor-in-chiefofeLife.CourtesyNoahBerger/AP/HHMIPioneeringlifesciencesjou

          read more
          Psychedelics group wrestles with new pharma identity
          Psychedelics group wrestles with new pharma identity

          OliviaGoldhill/STATDENVER—Hecouldhavebeenarockstar,areligiousicon,thewayecstaticapplausefromthousand

          read more

          SCOTUS to consider access to abortion pill mifepristone

          AprotesterstandsoutsidetheSupremeCourtinWashingtoninApril2023.ShuranHuang/TheNewYorkTimesWASHINGTON—